Hyperpolarized 13C-Pyruvate MRI
Early Cancer Treatment Response Assessment
Pre-clinical/Clinical DevelopmentActive
Key Facts
Indication
Early Cancer Treatment Response Assessment
Phase
Pre-clinical/Clinical Development
Status
Active
Company
About NVision Imaging
NVision Imaging is pioneering metabolic magnetic resonance imaging (MRI) by commercializing a quantum-based hyperpolarization technology called POLARIS. This technology enhances the MRI signal of natural metabolic agents by over 10,000x, allowing existing MRI scanners to visualize cellular-level metabolic activity in near real-time. The primary application is the early differentiation of resistant versus sensitive tumors within days of starting cancer therapy, enabling adaptive treatment strategies. The company's platform also has potential applications across cardiology, hepatology, neurology, and other therapeutic areas.
View full company profile